WEI REN enters ASCENTAGE PHARMA GROUP INTERNATIONAL with 8.96K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/23/2026ACC: 0001213900-26-033135
Director
Since Mar 2026
8.96K
Baseline shares
100% direct
8.96K
Direct ownership
1 position
47.70K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned8.96K
Total
8.96K direct8.96K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 8.96K | Direct |
| Total | 8.96K | 8.96K direct |
Derivative Holdings2
Options
DirectUnderlying security
Ordinary Shares
Underlying shares
18.85K
Shares owned
N/A
Exercise price
8.14
Expiration
—
Exercise window
—
Restricted share units
DirectUnderlying security
Ordinary Shares
Underlying shares
28.85K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
47.70K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options Direct | Ordinary Shares | 8.14 | — | — | 18.85K | N/A |
| Restricted share units Direct | Ordinary Shares | 0 | — | — | 28.85K | N/A |
| Total | 47.70K | 0.00 | ||||